Institute for Clinical and Experimental Surgery, University of Saarland, 66421, Homburg/Saar, Germany.
Langenbecks Arch Surg. 2010 Apr;395(4):387-94. doi: 10.1007/s00423-010-0603-8. Epub 2010 Mar 17.
Lipopolysaccharide (LPS) represents a highly toxic substance which may aggravate morbidity and mortality in septic diseases. A recent study has reported that the induction of heme oxygenase (HO)-1 protects from LPS-induced liver injury. The mechanisms of action however, have not been clarified yet. Therefore, we analyzed in vivo the effects of HO-1 on the liver microcirculation under conditions of LPS exposure.
In C57BL/6 mice, endotoxemia was induced by intraperitoneal (i.p.) administration of LPS (500 microg/kg) and D-galactosamine (Gal, 800 mg/kg). HO-1 was induced in vivo by pretreatment with hemin dissolved in DMSO (50 micromol/kg i.p.). Animals treated with DMSO only served as controls. Six hours after LPS exposure the hepatic microcirculation and leukocyte-endothelial cell interaction were analyzed by intravital fluorescence microscopy. HO-1 expression was determined by Western blot analysis. Hepatocellular damage was assessed by measuring the serum levels of aspartate aminotransferase and alanine aminotransferase. In addition, leukocyte transmigration and hepatocellular apoptosis were analyzed by histology and immunohistochemistry.
In controls, LPS/Gal caused severe liver injury, as indicated by increased liver enzyme levels and apoptotic cell death. This was associated with distinct sinusoidal perfusion failure and microvascular intrahepatic leukocyte accumulation. Of interest, induction of HO-1 significantly reduced numbers of adherent and extravascular leukocytes when compared to controls. Moreover, microvascular perfusion was significantly improved, resulting in a decrease of AST and ALT and a reduction of hepatocellular apoptosis.
Our novel data indicate that induction of HO-1 protects the liver from LPS-mediated injury by reducing leukocytic inflammation and improving intrahepatic microcirculation.
脂多糖(LPS)是一种高度毒性的物质,可能会加重脓毒症患者的发病率和死亡率。最近的一项研究报告称,血红素加氧酶-1(HO-1)的诱导可防止 LPS 诱导的肝损伤。然而,其作用机制尚未阐明。因此,我们在 LPS 暴露的情况下,在体内分析了 HO-1 对肝脏微循环的影响。
在 C57BL/6 小鼠中,通过腹腔内(i.p.)给予 LPS(500μg/kg)和半乳糖胺(Gal,800mg/kg)来诱导内毒素血症。通过用 DMSO 溶解的血红素(50μmol/kg i.p.)预先处理来诱导体内的 HO-1。仅用 DMSO 处理的动物作为对照。在 LPS 暴露 6 小时后,通过活体荧光显微镜分析肝微循环和白细胞-内皮细胞相互作用。通过 Western blot 分析测定 HO-1 表达。通过测量血清中天冬氨酸氨基转移酶和丙氨酸氨基转移酶的水平来评估肝细胞损伤。此外,通过组织学和免疫组织化学分析白细胞迁移和肝细胞凋亡。
在对照组中,LPS/Gal 导致严重的肝损伤,表现为肝酶水平升高和细胞凋亡增加。这与明显的窦状隙灌注衰竭和肝内微血管白细胞积聚有关。有趣的是,与对照组相比,HO-1 的诱导显著减少了粘附和血管外白细胞的数量。此外,微血管灌注明显改善,导致 AST 和 ALT 降低,肝细胞凋亡减少。
我们的新数据表明,HO-1 的诱导通过减少白细胞炎症和改善肝内微循环来保护肝脏免受 LPS 介导的损伤。